Log in to search using one of your social media accounts:

 

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
Conclusion In this AGC registry, the use of chemotherapy with schedules adapted to patients ≥70 years provided efficacy that was not inferior to that seen in younger cases, with comparable adverse effects. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 12, 2017 Category: Cancer & Oncology Source Type: research

The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
Conclusion Obesity was not correlated with adverse relapse or survival outcome, and grade≥3 toxicities were not greater with ABW-based dosing. This supports safety and efficacy of ABW-based dosing as per the 2012 ASCO clinical practice guideline. ClinicalTrials.gov Identifier: NCT00024102 (49907). (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 8, 2017 Category: Cancer & Oncology Source Type: research

Trimodality therapy for older patients with bladder cancer: Overtreatment or benefit?
Publication date: Available online 8 December 2017 Source:Journal of Geriatric Oncology Author(s): Marta Bonet, Teresa Bonfill, Miriam Nuñez, Encarna Mur, Meritxell Arenas (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 8, 2017 Category: Cancer & Oncology Source Type: research

Moving beyond symptom management towards cancer rehabilitation for older adults: Answering the 5W's
This report utilizes examples of three popular geriatric, distress and symptom measures to help answer these questions. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 7, 2017 Category: Cancer & Oncology Source Type: research

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study
Conclusion Identification of risk factors in older patients before BC surgery could help prevent postoperative ED visits. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 29, 2017 Category: Cancer & Oncology Source Type: research

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Conclusion Our results show that symptom burden and diminished QOL in an older breast cancer population receiving adjuvant TC chemotherapy are short-lived and disappear after a while with no long-term differences compared to a similar population not receiving chemotherapy. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience
Conclusion Brachytherapy is feasible in selected older patients with penile carcinoma, with efficacy and toxicity rates comparable to that of other series in younger patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Recent cancer treatment and memory decline in older adults: An analysis of the 2002 –2012 Health and Retirement Study
Conclusion Our results support a potential association between recent cancer treatment and trajectories of memory decline in older adults and provide guidance on the interpretation of statistical estimates from panel studies of health and aging. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Safety and efficacy of eribulin for “real-world” older patients with metastatic breast cancer
Publication date: Available online 22 November 2017 Source:Journal of Geriatric Oncology Author(s): Alexandre de Nonneville, Renaud Sabatier, Anthony Gonçalves, Jean-Marc Extra, Carole Tarpin, Simon Launay, Louis Tassy, Patrice Viens, Frederique Rousseau (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer
Conclusions Findings suggest that, compared to women with no comorbidity, patients with breast cancer age 70 and older with severe comorbidity are at increased risk of dying from breast cancer, even after adjustment for adjuvant chemotherapy and other tumor and treatment differences. This information adds to risk–benefit discussions and emphasizes the need for further study of the role for adjuvant chemotherapy in these patient groups. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Erratum to “Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG)” [J Geriatr Onco l 8 (2017) 262–270]
Publication date: Available online 24 November 2017 Source:Journal of Geriatric Oncology Author(s): Heike Schmidt, Stephanie Boese, Katharina Lampe, Karin Jordan, Eckhard Fiedler, Ursula Müller-Werdan, Andreas Wienke, Dirk Vordermark (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS)
Conclusions In current daily practice in Belgium, half of older patients with colorectal cancer treated with chemotherapy also receive bevacizumab. Nearly half of older patients presented with severe toxicity during treatment. Baseline nutritional status is a predictive marker for PFS. Patients with a baseline ECOG-PS≥2 have shorter PFS and higher risk of severe toxicity and should therefore be treated with caution. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 10, 2017 Category: Cancer & Oncology Source Type: research

Risk stratification for surgical outcomes in older colorectal cancer patients using ISAR-HP and G8 screening tools
Conclusions ISAR-HP-frail patients are at risk for adverse outcomes after colorectal surgery. ISAR-HP combined with G8 has the strongest predictive value for complications and mortality. Key Points Patients screening frail on ISAR-HP are at increased risk for morbidity and mortality. Screening results of G8 alone was not predictive for postoperative outcomes. Predictive value increased when G8 and ISAR-HP were combined. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 10, 2017 Category: Cancer & Oncology Source Type: research

SIOG 2017 - Abstract Submission – Poster Presentations
Publication date: November 2017 Source:Journal of Geriatric Oncology, Volume 8, Supplement 1 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 26, 2017 Category: Cancer & Oncology Source Type: research

SIOG 2017 - Abstract Submission – Oral Presentations
Publication date: November 2017 Source:Journal of Geriatric Oncology, Volume 8, Supplement 1 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 26, 2017 Category: Cancer & Oncology Source Type: research

SIOG 2017 - Invited Speakers Abstract Submission
Publication date: November 2017 Source:Journal of Geriatric Oncology, Volume 8, Supplement 1 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 26, 2017 Category: Cancer & Oncology Source Type: research

SIOG 2017 - Contents
Publication date: November 2017 Source:Journal of Geriatric Oncology, Volume 8, Supplement 1 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 26, 2017 Category: Cancer & Oncology Source Type: research

SIOG 2017 - Invited Speaker Biographies
Publication date: November 2017 Source:Journal of Geriatric Oncology, Volume 8, Supplement 1 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 26, 2017 Category: Cancer & Oncology Source Type: research

The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies
Conclusion Despite treatment with novel agents for RRMM in 86% of patients, an outcome gap persists for older patients and those with RI and/or CVD. Personalized treatment approaches that account for age and comorbidities, and further evaluation of innovative regimens and dosing schedules, are needed to improve outcomes for these patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 20, 2017 Category: Cancer & Oncology Source Type: research

Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial
Conclusion GA evaluation was feasible. KPS significantly correlated with efficacy outcomes. Items of a GA and biomarkers of inflammation and nutrition may have prognostic significance in patients with MBC. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 18, 2017 Category: Cancer & Oncology Source Type: research

Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly
Publication date: Available online 10 October 2017 Source:Journal of Geriatric Oncology Author(s): Angéline Galvin, Fleur Delva, Catherine Helmer, Muriel Rainfray, Carine Bellera, Virginie Rondeau, Pierre Soubeyran, Gaëlle Coureau, Simone Mathoulin-Pélissier Studies on cancer survival have revealed disparities not only between the elderly and their younger counterparts, but also among the elderly themselves. The aim of this work was to identify sociodemographic, socioeconomic, clinical, and care-related determinants of survival or mortality in older patients with cancer by a systematic synthesis of the ...
Source: Journal of Geriatric Oncology - October 11, 2017 Category: Cancer & Oncology Source Type: research

The impact of postoperative complications on health-related quality of life in older patients with rectal cancer; a prospective cohort study
Conclusion Older patients undergo more often a tailored treatment approach for rectal cancer than younger patients. With this tailored approach, similar postoperative complication rates and QOL are achieved. However, postoperative complications have a larger negative impact on physical- and role functioning in older patients which indicates a need for better prediction of postoperative complications in the elderly. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 10, 2017 Category: Cancer & Oncology Source Type: research

A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico
Conclusion Using smartphones to monitor older adults with cancer receiving chemotherapy in a resource-constrained setting is feasible and acceptable. A decrease in the number of daily steps was common and helped to identify chemotherapy toxicity. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 8, 2017 Category: Cancer & Oncology Source Type: research

Necessity of D2 lymph node dissection in older patients ≥80years with gastric cancer
Conclusions D2 or more LN dissection did not improve survival, but rather increased the risk of complications. Thus, LN dissection should be performed sparingly in octogenarian patients with gastric cancer. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 5, 2017 Category: Cancer & Oncology Source Type: research

In memory of Claude Jasmin: A prophet of Geriatric Oncology
Publication date: Available online 1 October 2017 Source:Journal of Geriatric Oncology Author(s): Lodovico Balducci (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - October 2, 2017 Category: Cancer & Oncology Source Type: research

The SIOG Treviso course: Students' perspective
Publication date: Available online 22 September 2017 Source:Journal of Geriatric Oncology Author(s): Cecilia M. Lund, Shane O'Hanlon (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 23, 2017 Category: Cancer & Oncology Source Type: research

Pearls of optimizing nutrition and physical performance of older adults undergoing cancer therapy
Publication date: Available online 22 September 2017 Source:Journal of Geriatric Oncology Author(s): Antonio Vigano, Popi Kasvis, Jonathan Di Tomasso, Chelsia Gillis, Robert Kilgour, Franco Carli As the global population continues to age, the prevalence of cancer is increasing, with more than half of new cancer diagnoses occurring in those aged 65years and older. As a result of improved oncological care, a greater number of older patients undergo treatment, either chemoradiotherapy or surgery or both. The older oncology patient is not part of a homogenous group; chronological age poorly describes the health status of an i...
Source: Journal of Geriatric Oncology - September 23, 2017 Category: Cancer & Oncology Source Type: research

Are prostate biopsies necessary for all patients 75years and older?
Conclusions The present nomograms could help discriminate patients with PCa from healthy elder adults for standard treatment, and discriminate patients with HGPCa from vulnerable elder adults for modified treatment. External validation is expected. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 21, 2017 Category: Cancer & Oncology Source Type: research

Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy
Conclusion Frailty is associated with lower OS in older patients with early stage NSCLC treated with SBRT, yet frail patients survived a median 2.5years, and were more likely to die of causes unrelated to the primary lung cancer, suggesting SBRT should be considered even in older patients deemed unfit for surgery. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 21, 2017 Category: Cancer & Oncology Source Type: research

The oldest old within the comprehensive home palliative care program of the ANT Foundation in Italy for advanced cancer patients
Publication date: Available online 15 September 2017 Source:Journal of Geriatric Oncology Author(s): Andrea A. Martoni, Brunella Boltri, Elena Strocchi, Franco Pannuti (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 16, 2017 Category: Cancer & Oncology Source Type: research

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)
Conclusions Challenges were experienced in conducting the first prospective phase III study evaluating progression-free survival of older adults with advanced colorectal cancer receiving palliative chemotherapy with fluoropyrimidine/bevacizumab with or without oxaliplatin in the USA. Future efforts to evaluate treatment outcomes in the older adult population should reflect on lessons learned in this large national effort. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 14, 2017 Category: Cancer & Oncology Source Type: research

A prospective comparison of younger and older patients' preferences for breast-conserving surgery versus mastectomy in early breast cancer
Publication date: Available online 12 September 2017 Source:Journal of Geriatric Oncology Author(s): Victoria C. Hamelinck, Esther Bastiaannet, Arwen H. Pieterse, Jos W.S. Merkus, Ilse Jannink, Irma D.M. den Hoed, Cornelis J.H. van de Velde, Gerrit-Jan Liefers, Anne M. Stiggelbout (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 12, 2017 Category: Cancer & Oncology Source Type: research

Are phase I trials safe for older patients?
Publication date: Available online 8 September 2017 Source:Journal of Geriatric Oncology Author(s): Capucine Baldini, Olivia Le Saux, Carole Helissey, Sandrine Aspeslagh, Eduardo Castanon, Andreea Varga, Anas Gazzah, Rastio Bahleda, Olivier Mir, Christophe Massard, Jean-Charles Soria, Antoine Hollebecque Phase I clinical trials in oncology primarily aim to assess the toxicity profile of new drugs and determine recommended phase II doses (RP2D). Since the cancer rate increases with age and our population is continually aging, RP2D must necessarily be assessed in older patients. Few clinical studies include older patients, ...
Source: Journal of Geriatric Oncology - September 9, 2017 Category: Cancer & Oncology Source Type: research

Telehealth in older adults with cancer in the United States: The emerging use of wearable sensors
Publication date: Available online 6 September 2017 Source:Journal of Geriatric Oncology Author(s): John Shen, Arash Naeim As the aging and cancer populations in the world continue to increase, the need for complements to traditional geriatric assessments and the logical incorporation of fast and reliable telehealth tools have become interlinked. In the United States, studies examining the use of telehealth for chronic disease management have shown promising results in small groups. The implementation of health technology on a broader scale requires older adults to both accept and adapt such innovation into routine medica...
Source: Journal of Geriatric Oncology - September 7, 2017 Category: Cancer & Oncology Source Type: research

How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
Publication date: Available online 6 September 2017 Source:Journal of Geriatric Oncology Author(s): Marine Gilabert, Jean Luc Raoul, Frederique Rousseau Pancreatic adenocarcinoma is one of the most fatal cancers that frequently affects older patients. Limited data suggest that older patients are as likely to benefit from surgery, radiation, and chemotherapy as younger patients. The only potentially curative approach for pancreatic cancer is surgery but this is only performed in less than 20% of patients considered resectable. With improvements in surgical techniques, older patients without major comorbidities show a cours...
Source: Journal of Geriatric Oncology - September 7, 2017 Category: Cancer & Oncology Source Type: research

Functional impairment prior to major non-cardiac surgery is associated with mortality within one year in elderly patients with gastrointestinal, gynaecological and urogenital cancer: A prospective observational cohort study
Conclusion Functional assessments, such as ADL and TUG scores, as well as mild cognitive impairment, are predictors of long-term outcome in elderly cancer patients. Trial Registration German Clinical Trials Register (DRKS 00005150) (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 7, 2017 Category: Cancer & Oncology Source Type: research

Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer
Conclusion In older patients with esophageal cancer, trimodality therapy, compared to esophagectomy alone, is associated with improved overall survival and favorable pathologic and perioperative outcomes. Further studies are needed to identify which older patients are most suitable for trimodality therapy. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 6, 2017 Category: Cancer & Oncology Source Type: research

NutriCancer: A French observational multicentre cross-sectional study of malnutrition in elderly patients with cancer
Conclusion Malnutrition is prevalent in elderly patients with cancer, and more frequent than in younger patients. There is a need for an early integration of the nutritional counselling in patients with cancer, and particularly in the elderly. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 6, 2017 Category: Cancer & Oncology Source Type: research

Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025
Conclusions Cancer incidence is projected to increase in individuals between 65 and 74years of age. Lebanese and Middle Eastern physicians must implement adapted therapeutic strategies in the management of the increasing caseload among frail, elderly patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 4, 2017 Category: Cancer & Oncology Source Type: research

Fighting back against the dilution of the Comprehensive Geriatric Assessment
Publication date: Available online 1 September 2017 Source:Journal of Geriatric Oncology Author(s): Martine T.E. Puts, Shabbir M.H. Alibhai (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - September 1, 2017 Category: Cancer & Oncology Source Type: research

Patients' perceptions and attitudes on recurrent prostate cancer and hormone therapy: Qualitative comparison between decision-aid and control groups
Conclusions The DA was more effective than the SoC group in helping PCa patients understand the full implications of PSA testing and treatment; motivating shared decision-making, and support-seeking for anxiety relief. DA DVD interventions can be a useful patient education tool for bringing higher quality decision-making to prostate cancer care. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 31, 2017 Category: Cancer & Oncology Source Type: research

Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients
Conclusion This observational study highlighted that PP decreased over time but neither DDI nor PIM use were reduced. A pharmacist-led evaluation might help to manage these medication issues. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 27, 2017 Category: Cancer & Oncology Source Type: research

Frailty and skeletal muscle in older adults with cancer
Conclusions Muscle mass (measured as SMI) was poorly associated with a GA-based frailty index. Muscle density, which reflects muscle lipid content, was more associated with frailty. Although frailty and loss of muscle mass are both age-related conditions that are predictive of adverse outcomes, our results suggest they are separate entities. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 25, 2017 Category: Cancer & Oncology Source Type: research

Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index
Publication date: Available online 24 August 2017 Source:Journal of Geriatric Oncology Author(s): Xiaotao Zhang, Ming Sun, June M. McKoy, Nizar Noor Ali Bhulani, Vicente Valero, Carlos H. Barcenas, Uday R. Popat, Meghan Karuturi Sri, Jay B. Shah, Colin P. Dinney, Ann-Marie Hedberg, Richard Champlin, Debu Tripathy, Holly M. Holmes, John R. Stroehlein, Beatrice J. Edwards (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 25, 2017 Category: Cancer & Oncology Source Type: research

Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review
This study aimed to evaluate and quantify the inclusion of elderly/frail patients in RCTs of targeted therapies in mCRC. A systematic review using Medline, Scopus, Cochrane Database and ISI Web of Science was performed to identify all phase II/III RCTs of bevacizumab, cetuximab, panitumumab, regorafenib and aflibercept in mCRC until January 2015. Two reviewers independently performed studies selection, and data extraction. The protocol was registered in Prospero (CRD42015016163). Among 1,369, identified publications, 54 RCTs were selected. Nine RCTs (17%) excluded elderly patients; median age of the included population was...
Source: Journal of Geriatric Oncology - August 24, 2017 Category: Cancer & Oncology Source Type: research

Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults
Publication date: Available online 20 August 2017 Source:Journal of Geriatric Oncology Author(s): Li-Wen Huang, Rebecca L. Olin Treatment for the older adult with acute myeloid leukemia (AML) is challenging, due to both more aggressive disease biology as well as patient-related risk factors that limit tolerance of intensive chemotherapy. The use of prognostic models and comprehensive geriatric assessments can help hematologists evaluate the suitability of intensive chemotherapy for individual patients. For older patients considered fit for intensive chemotherapy, standard induction therapy should be given, followed by con...
Source: Journal of Geriatric Oncology - August 21, 2017 Category: Cancer & Oncology Source Type: research

Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study
Conclusion Older patients largely followed their cancer specialists' treatment recommendations. Most patients were satisfied with their treatment decision and were confident in their decisions. Seeking of second opinions was rare. More needs to be done to address the communication gaps and support needs of this population. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 19, 2017 Category: Cancer & Oncology Source Type: research

Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial
Conclusion A limited but consistent benefit on both OS and PFS was associated with the addition of aflibercept to FOLFIRI compared with placebo in patients <65 and ≥65years old, with a marked but manageable increase in the toxicity profile in older patients. Trial Registration clinicaltrials.gov NCT00561470 (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 17, 2017 Category: Cancer & Oncology Source Type: research

Clinical effectiveness of geriatric assessment for predicting the tolerability of outpatient chemotherapy in older adults with cancer
Publication date: Available online 9 August 2017 Source:Journal of Geriatric Oncology Author(s): Naomi Hayashi, Ayumu Matsuoka, Hidemi Goto, Momokazu Gotoh, Hitoshi Kiyoi, Yasuhiro Kodera, Masato Nagino, Fumio Nagashima, Yuichi Ando (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 10, 2017 Category: Cancer & Oncology Source Type: research

Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer
Conclusion In this study examining the predictive value of geriatric screening and GA in predicting CD≥2 30d-POCs, the G8 screening tool was associated in univariable analysis, but did not remain in multivariable analysis. In the G8≤14 group receiving GA, ADL was the only predictive GA variable. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - August 4, 2017 Category: Cancer & Oncology Source Type: research